Founded in 2021, Colossal Biosciences operates in biotechnology. The latest valuation stands at $25B (rumored). Its shares do not trade on a public exchange.
4 valuations. The latest, $25B rumored, was set by the Series Rumored in Jul 2026.
Tim DraperLEADTTony RobbinsLEAD
Breyer CapitalLEADWWinklevoss Capital ManagementLEAD
Draper Associates
Animoca BrandsBBold CapitalBBoost VCBBuilders VCGGreen Sands EquityRRichard GarriottPParis HiltonUUntamed PlanetAAnimal Capital
Arch VenturesFFirst Light Capital GroupJJazz Ventures+1 moreTim DraperTony RobbinsBreyer CapitalColossal Biosciences is an American biotechnology company based in Dallas, Texas, founded in 2021 by Harvard geneticist George Church and entrepreneur Ben Lamm to work toward de-extincting animals such as the woolly mammoth, the Tasmanian tiger and the dodo through genetic engineering. In April 2025 it announced three dire wolf pups, Romulus, Remus and Khaleesi, born through gene editing and cloning technology.
The company spun off its data-management software into a separate business, Form Bio, in September 2022, and its team has grown to include over 170 scientists and 95 scientific advisors.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Colossal Biosciences.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Colossal Biosciences availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Colossal Biosciences included.
Lead investors for each round are in the funding timeline.
The closest biotechnology peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Colossal Biosciences is a private company; its shares do not trade on a public exchange.
The last valuation is $25B (rumored, Jul 2026).
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
